A contraction response of the internal anal sphincter to Botulinum toxin: does low-pressure chronic anal fissure have a different pathophysiology?
- PMID: 20478002
- DOI: 10.1111/j.1463-1318.2010.02318.x
A contraction response of the internal anal sphincter to Botulinum toxin: does low-pressure chronic anal fissure have a different pathophysiology?
Abstract
Aim: A subset of low-pressure fissures is not associated with typical internal anal sphincter hypertonia and may involve a different pathophysiological mechanism. We aimed to assess the manometric response of the internal anal sphincter to botulinum toxin in low-pressure fissures compared to high-pressure fissures.
Method: Twenty five units of botulinum toxin (Botox(TM)) were injected directly into the internal anal sphincter. Maximum resting pressure (MRP) and maximum squeeze increment (MSI) were documented at baseline and four weeks after injection.
Results: Nine (31%) of 29 patients had a low-pressure fissure. Those with an anterior fissure had a significantly lower median baseline MRP than those with a posterior fissure (66 vs 83 mmHg, P = 0.009). Significantly more patients with low-pressure fissures developed a contraction or no response (78%vs 30%, difference 48%, 95% CI 14-82%, P = 0.006). Those developing a contraction response had a lower mean baseline MRP than those developing a relaxation response (56 vs 86 mmHg, difference 30 mmHg, 95% CI 17-43%, P < 0.001).
Conclusion: Botulinum toxin appears to have an atypical contraction effect on the internal anal sphincter in low-pressure (usually anterior) fissures. This may be accounted for by blockade of acetylcholine released at parasympathetic nerve terminals and the sympathetic ganglion (relaxation). Low pressure fissures may be physiologically different from high-pressure fissures.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.
Similar articles
-
Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a non-randomized controlled trial.BMC Gastroenterol. 2004 Mar 22;4:7. doi: 10.1186/1471-230X-4-7. BMC Gastroenterol. 2004. PMID: 15035674 Free PMC article. Clinical Trial.
-
Prospective manometric assessment of botulinum toxin and its correlation with healing of chronic anal fissure.Dis Colon Rectum. 2005 Jul;48(7):1424-31. doi: 10.1007/s10350-005-0025-9. Dis Colon Rectum. 2005. PMID: 15906131
-
A comparison of botulinum toxin and saline for the treatment of chronic anal fissure.N Engl J Med. 1998 Jan 22;338(4):217-20. doi: 10.1056/NEJM199801223380402. N Engl J Med. 1998. PMID: 9435326 Clinical Trial.
-
Fissure-in-ano, to divide or not to divide?Acta Chir Belg. 1999 Oct;99(5):215-20. Acta Chir Belg. 1999. PMID: 10582070 Review.
-
[Botulinum toxin and chronic anal fissure].Gastroenterol Clin Biol. 2006 May;30(5):687-95. doi: 10.1016/s0399-8320(06)73262-6. Gastroenterol Clin Biol. 2006. PMID: 16801892 Review. French.
Cited by
-
High Anal Canal Pressure and Rectal Washouts Contribute to the Decrease of Anal Basal Pressure After Botulinum Toxin Injections in Paediatric Patients With Chronic Constipation.Front Pediatr. 2022 Mar 22;10:819529. doi: 10.3389/fped.2022.819529. eCollection 2022. Front Pediatr. 2022. PMID: 35391742 Free PMC article.
-
Anal fissure.Clin Colon Rectal Surg. 2011 Mar;24(1):22-30. doi: 10.1055/s-0031-1272820. Clin Colon Rectal Surg. 2011. PMID: 22379402 Free PMC article.
-
From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction.Toxins (Basel). 2024 Feb 10;16(2):96. doi: 10.3390/toxins16020096. Toxins (Basel). 2024. PMID: 38393175 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical